FARONFaron Pharmaceuticals Oy
0.4820EUR+3.32%Mkt Cap: 106.29M $P/E: —3d ago
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidate is Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap106.29M $
Enterprise Value71.46M $
Revenue (TTM)1.42M $
Gross Profit1.42M $
Net Income (TTM)-29.63M $
Revenue/Share0.0130 USD
Last Price0.4820 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees33
CountryFI
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.66
PEG—
EV/EBITDA-3.28
EV/Revenue50.26
P/S74.14
P/B-2.95
EPS (TTM)-0.22
EPS (Forward)-0.18
52W Range
0.43652% of range2.770
52W High2.770 EUR
52W Low0.4365 EUR
Profitability
Gross Margin100.00%
Oper. Margin-638.99%
EBITDA Margin0.00%
Profit Margin0.00%
ROE147.28%
ROA-158.73%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.48M $
CapEx (TTM)241.30K $
FCF Margin-866.94%
FCF Yield-11.60%
Net Debt13.44M $
Net Debt/EBITDA-0.62
Balance Sheet
Debt/Equity-1.33
Current Ratio0.84
Quick Ratio0.68
Book Value/Sh-0.1620 EUR
Cash/Share0.1080 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.413 EUR
Upside (mean)+193.0%
Target Range0.7500 EUR – 2.500 EUR
€0.7500+193.0% to mean€2.500
# Analysts4
Ownership
Shares Out.202.88M
Float90.41M
Insiders16.44%
Institutions22.27%
Technical
SMA 500.4865 (-0.9%)
SMA 2001.039 (-53.6%)
Beta1.12
S&P 52W Chg18.16%
Avg Vol (30d)340.74K
Avg Vol (10d)296.56K
Technical Indicators
RSI (14)52.5
MACD-0.0045
MACD Signal-0.0050
MACD Hist.+0.0006
BB Upper0.4888 EUR
BB Middle0.4760 EUR
BB Lower0.4633 EUR
BB Width5.36%
ATR (14)0.0121 EUR
Vol Ratio (20d)1.15x